However, in TCGA pan-cancer data, breast cancer (BRCA) showed a lower frequency of FOXM1 mRNA, protein expression, and genomic amplifications compared to HGSC (Figure 1A,B; Figure 2A). This evidence concerns the gene FOXM1 and breast cancer.